1,125 assets in Non-Small Cell Lung Carcinoma

Therapeutic assets addressing Non-Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tcr-T Cells Non-Small Cell Lung Carcinoma	Beijing Geekgene Technology Co., LTD	P1	CC (43)
Tcr Transduced T-Cells Non-Small Cell Lung Carcinoma	National Cancer Institute (NCI)	P2	CC (43)
Tegavivint Non-Small Cell Lung Carcinoma	Ohio State University Comprehensive Cancer Center	P1	CC (43)
th9619 Non-Small Cell Lung Carcinoma	One-carbon Therapeutics AB	P1/2	CC (43)
tqb2101 for Non-Small Cell Lung Carcinoma	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	P2	CC (43)
Triptolide Analog Non-Small Cell Lung Carcinoma	City of Hope Medical Center	P1	CC (43)
Tsc-200-A0201 Non-Small Cell Lung Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-201-B0702 Non-Small Cell Lung Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-202-A0201 Non-Small Cell Lung Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-203-A0201 Non-Small Cell Lung Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-204-A0101 Non-Small Cell Lung Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-204-A0201 Non-Small Cell Lung Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Tsc-204-C0702 Non-Small Cell Lung Carcinoma	TScan Therapeutics, Inc.	P1	CC (43)
Vancomycin Non-Small Cell Lung Carcinoma	National Cancer Institute (NCI)	P1	CC (43)
Vismodegib Non-Small Cell Lung Carcinoma	Dwight Owen	P1	CC (43)
Yttrium-90-Labeled Fibroblast Activation Protein Inhibitor Non-Small Cell Lung Carcinoma	Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization	P2	CC (43)
Zanidatamab Non-Small Cell Lung Carcinoma	UNICANCER	P2	CC (43)
Zoldonrasib Non-Small Cell Lung Carcinoma	Revolution Medicines, Inc.	P1/2	CC (43)
Alflutinib Non-Small Cell Lung Carcinoma	The First Affiliated Hospital of Henan University of Science and Technology	P2/3	CC (42)
Cxcr5 Modified Egfr Chimeric Antigen Receptor Autologous T Cells Non-Small Cell Lung Carcinoma	Sun Yat-sen University	P1	CC (42)
Imm-6-415 Non-Small Cell Lung Carcinoma	Immuneering Corporation	P1/2	CC (42)
Pimasertib Non-Small Cell Lung Carcinoma	Day One Biopharmaceuticals, Inc.	P1/2	CC (42)
Vidutolimod Non-Small Cell Lung Carcinoma	Regeneron Pharmaceuticals	P2	CC (42)
a2b530 Non-Small Cell Lung Carcinoma	A2 Biotherapeutics Inc.	P1/2	CC (41)
a2b543 Non-Small Cell Lung Carcinoma	A2 Biotherapeutics Inc.	P1/2	CC (41)
a2b694 Non-Small Cell Lung Carcinoma	A2 Biotherapeutics Inc.	P1/2	CC (41)
Abt-101 Non-Small Cell Lung Carcinoma	Anbogen Therapeutics, Inc.	P1/2	CC (41)
Adu-1805 Non-Small Cell Lung Carcinoma	Sairopa B.V.	P1	CC (41)
ak119 Non-Small Cell Lung Carcinoma	Akeso	P1/2	CC (41)
Alintegimod Non-Small Cell Lung Carcinoma	7 Hills Pharma, LLC	P1/2	CC (41)
Alta3263 Non-Small Cell Lung Carcinoma	Alterome Therapeutics, Inc.	P1	CC (41)
alx2004 Non-Small Cell Lung Carcinoma	ALX Oncology Inc.	P1	CC (41)
Amxt1501 Non-Small Cell Lung Carcinoma	Aminex Therapeutics, Inc.	P1/2	CC (41)
Arog4-01 Non-Small Cell Lung Carcinoma	Aromics Therapeutics	P1	CC (41)
asp0739 Non-Small Cell Lung Carcinoma	Astellas Pharma Global Development, Inc.	P1/2	CC (41)
Autologous Dendritic Cell-Adenovirus Ccl21 Vaccine Non-Small Cell Lung Carcinoma	Jonsson Comprehensive Cancer Center	P1	CC (41)
azd8853 Non-Small Cell Lung Carcinoma	AstraZeneca	P1/2	CC (41)
Bevacizumab-Awwb Non-Small Cell Lung Carcinoma	Criterium, Inc.	P1/2	CC (41)
bi-1910 Non-Small Cell Lung Carcinoma	BioInvent International AB	P1/2	CC (41)
Cea-Targeted Car-T Non-Small Cell Lung Carcinoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (41)
Cish Inactivated Tumor Infiltrating Lymphocytes Non-Small Cell Lung Carcinoma	Intima Bioscience, Inc.	P1/2	CC (41)
Cjrb-101 Non-Small Cell Lung Carcinoma	CJ Bioscience, Inc.	P1/2	CC (41)
Davutamig Non-Small Cell Lung Carcinoma	Regeneron Pharmaceuticals	P1/2	CC (41)
Difluoromethylornithine Non-Small Cell Lung Carcinoma	H. Lee Moffitt Cancer Center and Research Institute	P1/2	CC (41)
Eflornithine Non-Small Cell Lung Carcinoma	Aminex Therapeutics, Inc.	P1/2	CC (41)
Env-501 Non-Small Cell Lung Carcinoma	Hummingbird Bioscience	P1/2	CC (41)
ep0031 Non-Small Cell Lung Carcinoma	Ellipses Pharma	P1/2	CC (41)
Fmc-376 Non-Small Cell Lung Carcinoma	Frontier Medicines Corporation	P1/2	CC (41)
fwd1509 msoh Non-Small Cell Lung Carcinoma	Forward Pharmaceuticals Co., Ltd.	P1/2	CC (41)
Gavo-Cel Non-Small Cell Lung Carcinoma	TCR2 Therapeutics	P1/2	CC (41)

Showing 651 to 700 of 1,125 assets

PreviousPage 14 of 23Next